The global kidney function tests market size is expected to reach USD 1.26 billion by 2028 according to a new study by Polaris Market Research. The report “Kidney Function Tests Market Share, Size, Trends, Industry Analysis Report, By Product (Clearance Tests, Urine Tests, Blood Tests, Dilution & Concentration Tests, Others), By End-Use (Hospitals, Diagnostic Laboratories, Research Laboratories & Institutes, Others), By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
There are several forms of kidney function tests that look at different aspects of renal function. A kidney function examination is used to determine whether the kidneys are removing waste products too slowly and whether proteins are leaking into the urine.
Regular insulin sensitivity tests can aid in the early detection of issues such as kidney failure, allowing the disease’s progression to be slowed. Urine checks, blood tests, imaging studies, and kidney biopsy are all examples of kidney function tests.
Market growth for kidney function tests is expected to be fueled by increased R&D activities, a higher incidence of kidney diseases, and increasing government initiatives. Kidney function tests are basic screening tests that are used to investigate and evaluate kidney functions.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/kidney-function-tests-market/request-for-sample
The increasing rate of diabetes and hypertension has increases the risk of Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD), which has sparked a rise in demand for these products. The COVID-19 pandemic has fueled the market demand for kidney function tests even further.
As per the CDC, an estimated 15% of adults in the United States had Chronic Kidney Disease in 2019. (CKD). Blood sugar and blood pressure are the leading causes of CKD in adults, and CKD is more prevalent in older people. The low detection rate of CKD, on the other hand, is expected to be a major stumbling block to market growth for kidney function tests. According to the National Kidney Foundation, nearly 90% of people with CKD are unaware of their condition, resulting in a low number of diagnoses.
Market participants such as F.Hoffmann-La Roche Ltd, Siemens Healthineers, C. R. Bard, Inc, Abbott Laboratories, Nova Biomedical, Baxter International Inc, Cook Medical, Boston Scientific Corporation, Danaher Corporation, and Sysmexare some of the key players operating in the market for kidney function tests.
RenalytixAI, for example, submitted a 510(k) approval to the FDA for its latest KidneyIntelX assay, in August 2020. It’s a clinical diagnostic test that uses Artificial Intelligence (AI) to identify and improve the clinical management of Type 2 diabetes patients with rapidly developing kidney disease. During the study era, the introduction of such advanced technologies is anticipated to accelerate market growth.
Polaris Market Research has segmented the kidney function tests market report based on product, end-use, and region:
Kidney Function Tests, Product Outlook (Revenue – USD Billion, 2016 – 2028)
- Clearance Tests
- Urine Tests
- Blood Tests
- Dilution and Concentration Tests
- Other Tests
Kidney Function Tests, End-Use Outlook (Revenue – USD Billion, 2016 – 2028)
- Diagnostic Laboratories
- Research Laboratories and Institutes
Kidney Function Tests, Regional Outlook (Revenue – USD Billion, 2016 – 2028)
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa